1. Home
  2. CINT vs FDMT Comparison

CINT vs FDMT Comparison

Compare CINT & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CI&T Inc

CINT

CI&T Inc

HOLD

Current Price

$4.70

Market Cap

646.9M

Sector

Technology

ML Signal

HOLD

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$9.86

Market Cap

515.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINT
FDMT
Founded
1995
2013
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
646.9M
515.6M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
CINT
FDMT
Price
$4.70
$9.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
7
Target Price
$7.35
$31.71
AVG Volume (30 Days)
68.6K
820.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.79
EPS
N/A
N/A
Revenue
N/A
$85,209,000.00
Revenue This Year
$16.69
N/A
Revenue Next Year
$11.28
$70.28
P/E Ratio
$17.94
N/A
Revenue Growth
N/A
230194.60
52 Week Low
$3.98
$2.96
52 Week High
$6.71
$12.34

Technical Indicators

Market Signals
Indicator
CINT
FDMT
Relative Strength Index (RSI) 42.42 55.60
Support Level $4.55 $9.85
Resistance Level $5.02 $10.69
Average True Range (ATR) 0.23 0.61
MACD -0.02 0.01
Stochastic Oscillator 33.33 62.55

Price Performance

Historical Comparison
CINT
FDMT

About CINT CI&T Inc

CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: